Skip to content

Clinical trials

Reperfusion Injury trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Reperfusion Injury Status: Unknown status Country / region: China Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20131
20152
20164
20172
20202
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese PLA General Hospital4
First Affiliated Hospital, Sun Yat-Sen University2
Central South University1
Chen Wei Ren, MD1
Mengya Liang1
Nanfang Hospital, Southern Medical University1
Nanjing First Hospital, Nanjing Medical University1
Qin Zhang1
RenJi Hospital1
Second Affiliated Hospital, Zhejiang University, School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Reperfusion Injury15
Cardiovascular Diseases2
Ischemic Stroke2
Kidney Tubular Necrosis, Acute2
Brain Edema1
Delayed Graft Function1
Hypothermia1
Liver Neoplasms1
Myocardial Infarction1
Myocardial Reperfusion Injury1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.